Benzylacetone is an aromatic ketone found in agarwood and other floral or food aroma systems, where it contributes a sweet floral-balsamic character. The strongest accessible evidence is good for identity and occurrence, and there is a small but directly relevant preclinical inhalation literature: mouse studies from Kyoto University reported sedative-style locomotor reduction after benzylacetone vapor exposure and identified benzylacetone as one active volatile in one agarwood oil sample. That makes this constituent reasonable to describe as an agarwood-linked aroma marker with early inhalation pharmacology, not as a clinically established wellness agent.
Chemical identity and composition
PubChem resolves benzylacetone as CID 17355 with formula C10H12O, InChIKey AKGGYBADQZYZPD-UHFFFAOYSA-N, and IUPAC name 4-phenylbutan-2-one. NIST lists the same substance under CAS 2550-26-7 and synonyms including Benzylacetone, 4-Phenyl-2-butanone, and Methyl phenethyl ketone. In the AromaForge archive, agarwood already records benzylacetone at 4.74% in a cited SPME/GC-MS paper.
Aroma and practical use
- Use the recorded sweet, floral, balsamic descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2008 mouse vapor-inhalation study reported that agarwood oil sedated mice and that benzylacetone reproduced the sedative effect seen with the agarwood oil sample in which it was a main volatile constituent.
A 2008 mouse vapor-inhalation study reported that agarwood oil sedated mice and that benzylacetone reproduced the sedative effect seen with the agarwood oil sample in which it was a main volatile constituent.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2013 mouse study reported that inhaled benzylacetone reduced locomotor activity and used a 17-derivative structure-activity comparison to show that sedative activity varied with benzylacetone side-chain and ring substitution features.
A 2013 mouse study reported that inhaled benzylacetone reduced locomotor activity and used a 17-derivative structure-activity comparison to show that sedative activity varied with benzylacetone side-chain and ring substitution features.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A high-quality agarwood-oil composition paper used in the archive reported 4-phenyl-2-butanone at 4.74% in one analyzed agarwood oil sample.
A high-quality agarwood-oil composition paper used in the archive reported 4-phenyl-2-butanone at 4.74% in one analyzed agarwood oil sample.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedThe reviewed benefit-facing literature is limited to preclinical inhalation work in mice and should not be translated into medical or sleep-treatment claims for people.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
No constituent-specific IFRA dermal limit, phototoxicity warning, or controlled human tolerability study was verified in this research pass for isolated benzylacetone.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
inhalation linked locomotor reduction
The available mouse studies describe reduced spontaneous locomotor activity after vapor inhalation, indicating a central sedative-style preclinical effect without confirming a specific receptor-level mechanism.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- No human clinical trials specific to isolated benzylacetone were located in the reviewed public sources.
- The inhalation activity literature is narrow and animal-based, with no verified receptor-level mechanism established in the sources reviewed here.
- Constituent-specific dermal sensitization, inhalation safety, and long-term toxicology data were not verified in this pass.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.